Hyperbaric Oxygen Therapy is NOT Recommended for Healthy Individuals in the General Population
No, hyperbaric oxygen therapy should not be used by healthy individuals in the general population, as there is no evidence of meaningful clinical benefit and the therapy carries significant safety risks including chamber explosion, fire, and oxygen toxicity.
Evidence-Based Rationale
The available evidence exclusively addresses hyperbaric oxygen therapy (HBOT) for specific medical conditions - not for use in healthy populations seeking general wellness or performance enhancement.
Established Medical Indications Only
All guideline evidence 1 focuses on HBOT for carbon monoxide poisoning and other acute medical emergencies. These guidelines make no mention of benefits for healthy individuals and emphasize that HBOT is a medical treatment for specific pathological conditions where tissue hypoxia or ischemia exists.
Lack of Performance Benefits in Healthy Individuals
Research examining HBOT in healthy, physically active adults demonstrates:
- No significant improvement in exercise performance when HBOT is administered before exercise 2
- No significant improvement in recovery when HBOT is administered after exercise 2
- The 2021 meta-analysis explicitly concluded that "the practical relevance of these findings should be treated with caution" 2
While one pilot study 3 showed increased microcirculation in peripheral tissues, this physiological change has not translated into any demonstrated improvement in morbidity, mortality, or quality of life outcomes in healthy individuals.
Significant Safety Concerns
HBOT carries potentially life-threatening risks that are unacceptable when no medical indication exists 4:
- Chamber explosion and/or fire - catastrophic events that can occur in both traditional and mild hyperbaric settings
- Oxygen free radical damage from systemic hyperoxia, particularly with traditional HBOT protocols 4
- Barotrauma (ear discomfort, sinus injury)
- Oxygen toxicity with prolonged or repeated exposures
The 2026 safety review 4 emphasizes that "compliance with safety standards is not universally mandated and may vary among facilities," raising additional concerns about unregulated use in wellness settings.
No Established Dosing or Protocols for Healthy Individuals
Even for established medical indications like carbon monoxide poisoning, "the optimal dose and frequency of hyperbaric oxygen treatments remain unknown" 1. There are no evidence-based protocols for healthy individuals because this is not an appropriate use of the therapy.
Common Pitfalls to Avoid
- Marketing claims: Many commercial hyperbaric facilities market HBOT for "wellness," "anti-aging," or "performance enhancement" without supporting evidence
- Confusing mild vs. traditional HBOT: Even "mild" hyperbaric oxygen (lower pressures, lower oxygen concentrations) carries risks and lacks evidence for healthy populations 4
- Extrapolating from disease states: Benefits seen in hypoxic or ischemic tissues do not apply to normally oxygenated healthy tissues
The Bottom Line
HBOT is a legitimate medical treatment for specific conditions involving tissue hypoxia or ischemia (carbon monoxide poisoning, decompression sickness, chronic non-healing wounds, etc.). For healthy individuals without these conditions, HBOT offers no demonstrated benefits while exposing them to unnecessary risks. The therapy should remain within the domain of evidence-based medical practice under appropriate supervision, not as a wellness intervention for the general population.